Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-017836
Filing Date
2025-06-20
Accepted
2025-06-20 16:09:25
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3275
  Complete submission text file 0001127602-25-017836.txt   4650
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address
Chopas James George (Reporting) CIK: 0001836430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 251061419